CN108339039A - A kind of Chinese medicine for the treatment of bone injury diseases - Google Patents

A kind of Chinese medicine for the treatment of bone injury diseases Download PDF

Info

Publication number
CN108339039A
CN108339039A CN201810520195.0A CN201810520195A CN108339039A CN 108339039 A CN108339039 A CN 108339039A CN 201810520195 A CN201810520195 A CN 201810520195A CN 108339039 A CN108339039 A CN 108339039A
Authority
CN
China
Prior art keywords
parts
chinese medicine
bone
fracture
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201810520195.0A
Other languages
Chinese (zh)
Other versions
CN108339039B (en
Inventor
郑方
郑华
郑伟晴
韩德生
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201810520195.0A priority Critical patent/CN108339039B/en
Publication of CN108339039A publication Critical patent/CN108339039A/en
Application granted granted Critical
Publication of CN108339039B publication Critical patent/CN108339039B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/28Mercury; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/254Acanthopanax or Eleutherococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286Carthamus (distaff thistle)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/32Burseraceae (Frankincense family)
    • A61K36/328Commiphora, e.g. mecca myrrh or balm of Gilead
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/56Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708Rheum (rhubarb)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/889Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Insects & Arthropods (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention discloses a kind of Chinese medicine for the treatment of bone injury diseases, the Chinese medicine is by following parts by weight Chinese medicinal composition:10 20 parts of dipsacus root, 5 15 parts of eupolyphoge sinensis, 5 15 parts of Semen Strychni (processed), 10 20 parts of myrrh, 15 25 parts of safflower, 5 15 parts of dragon's blood, 5 12 parts of cinnabar, 15 25 parts of rheum officinale, 25 35 parts of cortex acanthopanacis.It is an advantage of the invention that:Its prescription medicine compatibility is reasonable, has subsiding swelling and resolving stagnation, promoting blood circulation and stopping pain, reunion of fractured tendons and bones, hemostasis and pain-relieving, life is newly;The disease of bone fracture, non- muscle, that is, bone is hindered, muscle swelling, extravasated blood fracture etc., this prescription Chinese medicine is mostly the product of Return liver kidney, it is promoting blood circulation, is enhancing tissue metabolism, reinforcing complementing each other in terms of union, obvious effect, suitable for each position closed fracture of whole body and each position comminuted fracture, Preferred effects can be obtained by being not necessary to operation, significant in efficacy to osteoarthrosis such as neck, shoulder, waist, leg, treating rheumatic ostealgia, traumatic injuries, drug of the present invention is at low cost, short treating period, cure rate is high, and the recurrence after healing can be avoided.

Description

A kind of Chinese medicine for the treatment of bone injury diseases
Technical field
The invention belongs to technical field of Chinese medicine, and in particular to a kind of Chinese medicine for the treatment of bone injury diseases.
Background technology
Fracture refers to that the successional interruption of bone trabecula or integrality are destroyed, union be a variety of repair cells and The complex process of gene aggregation.Fracture is more common in children and the elderly, and a middle-aged person also happens occasionally.Patient is often a position bone Folding, minority are multiple fracture, and by appropriate processing in time, most patients can restore original function, and a few patients can be there are Different degrees of sequelae.Traditional Chinese medicine thinks that union is the process that a dissolving stasis, raw new, bone close, and develops that " dissolving stasis connects Bone is said " scheduling theory, also most of selections have a Chinese medicines of promoting blood circulation and removing blood stasis or help and other effects when clinical treatment is fractured, also neck, The patient of the bone diseases such as shoulder, waist, leg, arthralgia, rheumatism, rheumatoid increases year by year, becomes people's common disease, frequently-occurring disease, in Doctor think its pathogenic factor for exopathogen invasion, extravasated blood retention, hepatic and renal function is insufficient and blocking channels and collaterals, phlegm and blood stasis, knot in Caused by between bone.The method for treating these bone diseases at present mainly has operative treatment, physical therapy method, western medical treatment and Chinese traditional treatment, But expenses of surgical treatment is expensive, and increases the pain of patient, is easy to be formed new hyperplasia, and physical therapy method is suitable for the state of an illness compared with less serious case, Energy respite patient's pain, is not easy to effect a radical cure, western medicine is expensive, and has side effect, the Chinese traditional treatment bone of existing application Sick and wounded drug, often the course for the treatment of is long, takes effect slowly, curative effect is not fairly obvious, is not easy to be accepted.
Invention content
The object of the present invention is to provide a kind of Chinese medicines for the treatment of bone injury diseases, and the Chinese medicine is rapid-action, and treatment cycle is short, and curative effect is true It cuts, healing is uneasy to recur, and advantage of lower cost.
The technical solution adopted by the present invention is:A kind of Chinese medicine for the treatment of bone injury diseases, by following parts by weight Chinese medicinal composition:River 10-20 parts disconnected, 5-15 parts of eupolyphoge sinensis, 5-15 parts of Semen Strychni (processed), 10-20 parts of myrrh, 15-25 parts of safflower, 5-15 parts of dragon's blood, cinnabar 5-12 parts, 15-25 parts of rheum officinale, 25-35 parts of cortex acanthopanacis.
The Chinese medicine of above-mentioned treating bone injury diseases optimizes composition by weight:15 parts of dipsacus root, 10 parts of Semen Strychni (processed), does not have 10 parts of eupolyphoge sinensis 15 parts of medicine, 20 parts of safflower, 10 parts of dragon's blood, 10 parts of cinnabar, 20 parts of rheum officinale, 30 parts of cortex acanthopanacis.
In prescription:Blood vessels are adjusted in dipsacus root, bitterly, tepor, Return liver kidney channel, effect filling liver kidney, strengthening the bones and muscles, continue injured, living Blood and dissolving stasis is monarch drug in a prescription;Eupolyphoge sinensis taste is salty-cold, slightly poisonous, return liver warp, breaks extravasated blood, continuous muscles and bones;Semen Strychni (processed), bitter is cold, very toxic, returns Liver and spleen passes through, mass dissipating and swelling eliminating, leads to stasis of blood analgesic;Myrrh acrid flavour hardship is flat, thoughts of returning home liver and spleen warp, promoting blood circulation and stopping pain, myogenic swollen clearly;Safflower acrid flavour Temperature, thoughts of returning home Liver Channel, promoting blood circulation and removing obstruction in channels, stasis-dispelling and pain-killing is promoting blood circulation;Dragon's blood is sweet in flavor, salty, flat, return liver warp, and analgesic therapy of invigorating blood circulation, stagnation resolvation stops Blood, myogenic, said medicine are ministerial drug;Cinnabar is sweet in flavor to be slightly cold, and toxic, thoughts of returning home warp, tranquilizing the mind town is throbbed with fear, clearing heat and detoxicating, promoting blood circulation, strengthening the essence God;Rheum officinale bitter is cold, and returns spleen, stomach, large intestine, liver, pericardium channel, purge heat poison, breaks and stagnates, row extravasated blood, clearing heat-fire, removing pattogenic heat from the blood and toxic material from the body, By stasis of blood latus rectum, said medicine is adjutant;Cortex acanthopanacis sweet and slightly bitter taste, pungent-warm, returns spleen lung heart kidney channel, replenish qi to invigorate the spleen, tonify the kidney to relieve mental strain, by force Muscle strong bone, resisting stress, modern pharmacology think there is anti-inflammatory analgesic action, to make medicine, can mitigate slight illness, and bone fracture is accelerated to recover conjunction.
Compared with prior art, it is an advantage of the invention that:Its prescription medicine compatibility is reasonable, and there is subsiding swelling and resolving stagnation, promoting blood circulation to stop Bitterly, reunion of fractured tendons and bones, hemostasis and pain-relieving are raw new;The disease of bone fracture, non-muscle, that is, bone are hindered, muscle swelling, extravasated blood fracture etc., in this prescription Medicine is mostly the product of Return liver kidney, is being promoted blood circulation, and tissue metabolism is enhanced, and reinforces complementing each other in terms of union, effect is aobvious It writes, is suitable for each position closed fracture of whole body and each position comminuted fracture, Preferred effects can be obtained by being not necessary to operation, right The osteoarthrosis such as neck, shoulder, waist, leg, treating rheumatic ostealgia, traumatic injury are significant in efficacy, and drug of the present invention is at low cost, and short treating period is controlled More rate is high, and the recurrence after healing can be avoided.
Specific implementation mode
Below by way of the advantageous effect of clinical observation on the therapeutic effect experiment the present invention is further explained drug.
One, general information
Accept bone fracture patient 300 for medical treatment, male 200, women 100, the age was at 5 ~ 85 years old;
Two, diagnostic criteria
Fracture, bone fracture, cervical spondylosis, lumbar vertebra disease, scapulohumeral periarthritis, synovitis, arthritis, rheumatism bone disease and traumatic injury, have pain, The obstacles such as function limitation, X-ray or CT film diagnosis;
Three, therapy
Chinese medicine pulverized powder of the present invention can be made into ball and dissipate or filling capsule, each taking 9 grams, three times per day, 20 days as one therapeutic course.Gently One course for the treatment of of person is cured, and 2 courses for the treatment of of severe one are cured;
Four, efficacy assessment standard
It cures:After 1-2 courses for the treatment of take drug of the present invention, at bone fracture " muscle have a respite suitable, unobstructed vessel ", fracture is accelerated to be cured Close and surrounding tissue reparation, increase blood circulation, promote extravasated blood absorb, make osteocyte hyperplasia be denaturalized, calcification and ossify, finally reach It is connected to bone, repairs cartilage, pain disappears, and restores function;
It is effective:After taking drug of the present invention, some related symptoms start to improve, and such as pain relief, funtion part is restored, raw Bioplasm amount increases;
In vain:After taking drug of the present invention, all symptoms are without change;
Five, therapeutic effect
Healing 294, effective 6, invalid 0, total effective rate 100%.

Claims (2)

1. a kind of Chinese medicine for the treatment of bone injury diseases, it is characterised in that:The Chinese medicine is made of following parts by weight:10-20 parts of dipsacus root, 5-15 parts of eupolyphoge sinensis, 5-15 parts of Semen Strychni (processed), 10-20 parts of myrrh, 15-25 parts of safflower, 5-15 parts of dragon's blood, 5-12 parts of cinnabar, rheum officinale 15-25 parts, 25-35 parts of cortex acanthopanacis.
2. a kind of Chinese medicine for the treatment of bone injury diseases according to claim 1, it is characterised in that:The Chinese medicine optimizes composition by weight For:15 parts of dipsacus root, 10 parts of eupolyphoge sinensis, 10 parts of Semen Strychni (processed), 15 parts of myrrh, 20 parts of safflower, 10 parts of dragon's blood, 10 parts of cinnabar, rheum officinale 20 Part, 30 parts of cortex acanthopanacis.
CN201810520195.0A 2018-05-28 2018-05-28 Chinese medicine for treating bone injury Active CN108339039B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810520195.0A CN108339039B (en) 2018-05-28 2018-05-28 Chinese medicine for treating bone injury

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810520195.0A CN108339039B (en) 2018-05-28 2018-05-28 Chinese medicine for treating bone injury

Publications (2)

Publication Number Publication Date
CN108339039A true CN108339039A (en) 2018-07-31
CN108339039B CN108339039B (en) 2021-04-02

Family

ID=62955635

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810520195.0A Active CN108339039B (en) 2018-05-28 2018-05-28 Chinese medicine for treating bone injury

Country Status (1)

Country Link
CN (1) CN108339039B (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1454660A (en) * 2003-05-27 2003-11-12 单凤柱 Bone-setting medicine
CN1539484A (en) * 2003-10-31 2004-10-27 昌友权 Vulnerary for treating fracture
CN101612279A (en) * 2009-07-31 2009-12-30 徐先启 A kind of Chinese medicine preparation that promotes union of fracture
CN102078516A (en) * 2010-12-28 2011-06-01 闫忠彪 Traditional Chinese medicine for treating bone injury
CN104435768A (en) * 2014-09-22 2015-03-25 刘德刚 Traditional Chinese medicine for treating injuries from falls, fractures, contusions and strains

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1454660A (en) * 2003-05-27 2003-11-12 单凤柱 Bone-setting medicine
CN1539484A (en) * 2003-10-31 2004-10-27 昌友权 Vulnerary for treating fracture
CN101612279A (en) * 2009-07-31 2009-12-30 徐先启 A kind of Chinese medicine preparation that promotes union of fracture
CN102078516A (en) * 2010-12-28 2011-06-01 闫忠彪 Traditional Chinese medicine for treating bone injury
CN104435768A (en) * 2014-09-22 2015-03-25 刘德刚 Traditional Chinese medicine for treating injuries from falls, fractures, contusions and strains

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
王兆月: "软组织损伤的中医治疗", 《中国民族民间医药》 *
王永康: "止痛接骨散与接骨七厘片治疗骨伤效果比较", 《中国乡村医药》 *

Also Published As

Publication number Publication date
CN108339039B (en) 2021-04-02

Similar Documents

Publication Publication Date Title
CN101062194B (en) Medicine for treating bone disease and fracture and the preparing method thereof
CN101352505B (en) Bone fracture setting medicine powder for treating traumatic injury
CN103585590A (en) Rheumatism ostalgia plaster
CN106511510A (en) Medicine composition used for treating wind-cold-damp arthralgia and muscle and bone strain
CN103285200A (en) Traditional Chinese medicine for treating multiple osteopathies
CN104000993A (en) Pills with effects of strengthening bones and stretching muscles and tendons and preparation technology thereof
CN101912536B (en) Medicinal composition for treating rheumatism and rheumatoid disease
CN104288410B (en) Treat the traditional Chinese medicinal ointment of knee joint osseous arthritis
CN103877157B (en) A kind of bone-knitting Chinese medicament and preparation method thereof
CN101912458B (en) Medicament for treating protrasion of the lumbar intervertebral disci
CN102078586A (en) Medicament for treating cervical spondylosis
CN102274372B (en) Traditional Chinese medicine for treating traumatic fracture rheumatism and various types of hemorrhage
CN108339039A (en) A kind of Chinese medicine for the treatment of bone injury diseases
CN104840562A (en) External application of Chinese medicine for curing transient synovitis of the hip in children and nursing method
CN109966451A (en) A kind of Chinese medicine composition of bone-setting and pain-relieving
CN108420856A (en) The Chinese medicine preparation for the treatment of Bones and joints, grain pain
CN105168973B (en) A kind of Chinese medicine for treating cervical and lumbar diseases
CN102614350A (en) Chinese medicine for treating cervical spondylosis
CN102764355A (en) Traditional Chinese medicine composite for curing femoral head necrosis
CN106377615A (en) Traditional Chinese medicine composition for treating lumbar hyperplasia, cervical hyperplasia and spurs
CN106620104A (en) External plaster for treating removing dampness and relieving pain and preparation method thereof
CN104173652B (en) A kind of Chinese medicine composition for treating lumbar muscle strain
CN105267411B (en) A kind of pharmaceutical composition for treating fracture
CN105616052A (en) Treatment method for promoting healing of distal radius fracture
CN103990029A (en) Traditional Chinese medicine composition for treating rheumatoid arthritis

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant